Skip to content
Longterm Wiki has not been actively maintained since May 2026. Some data is still updated occasionally, but please don't rely on this site being current or accurate.
Longterm Wiki
Index
Grant·7llqxh3lU-·Record

Grant 7llqxh3lU-

Verdictunverifiable95%
2 checks · 1 src · 9/14/2026

1 → unverifiable; stale (excluded): 1 → confirmed

Our claim

entire record
Name
Results for Development — Childhood Pneumonia Treatment Scale-Up
Amount
$6,400,000
Currency
USD
Date
May 2016
Notes
[Global Health & Development] Published: March 2017 Note: This grant was awarded while the Open Philanthropy Project was a partnership between GiveWell and Good Ventures. Good Ventures, with input from GiveWell, awarded a grant of $6,400,000 to Results for Development (R4D) in… expand[Global Health & Development] Published: March 2017 Note: This grant was awarded while the Open Philanthropy Project was a partnership between GiveWell and Good Ventures. Good Ventures, with input from GiveWell, awarded a grant of $6,400,000 to Results for Development (R4D) in May of 2016 to support its Market Dynamics practice area’s pneumonia treatment program in Tanzania. R4D is a global nonprofit organization aiming to tackle development challenges to help those living in poverty. The organization aims to use these funds to increase use of amoxicillin, the WHO-recommended first-line treatment for childhood pneumonia. We are supporting R4D because we believe that, if successful, it could become a GiveWell-recommended charity. See GiveWell's writeup of this grant for more details.

Source evidence

1 src · 2 checks
unverifiable95%Haiku 4.5 · 9/14/2026

NoteRe-check. Previous verdict: unverifiable. Verdict unchanged.

confirmed95%deterministic-row-match · 6/22/2026
Name
Results for Development — Childhood Pneumonia Treatment Scale-Up
Grantee
Results for Development
Focus Area
Global Health & Development
Amount
$6,400,000.00
Date
May 2016

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № 7llqxh3lU-Filed 9/14/2026Confidence 95%